{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T09:48:23Z","timestamp":1785750503091,"version":"3.56.0"},"reference-count":117,"publisher":"Informa UK Limited","issue":"8","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2026,8,3]]},"DOI":"10.1080\/13543776.2026.2694586","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:09:09Z","timestamp":1782230949000},"page":"713-741","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["An updated patent review of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors (2020\u2013present)"],"prefix":"10.1080","volume":"36","author":[{"given":"Mennatallah","family":"Abdallah","sequence":"first","affiliation":[{"name":"German University in Cairo","place":["Cairo, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parthiena M.","family":"Keddis","sequence":"additional","affiliation":[{"name":"German University in Cairo","place":["Cairo, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevina M.","family":"Keddis","sequence":"additional","affiliation":[{"name":"German University in Cairo","place":["Cairo, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia S.","family":"El-Gamil","sequence":"additional","affiliation":[{"name":"Ahram Canadian University","place":["Cairo, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf H.","family":"Abadi","sequence":"additional","affiliation":[{"name":"German University in Cairo","place":["Cairo, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Kii","sequence":"additional","affiliation":[{"name":"Shinshu University","place":["Nagano, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Engel","sequence":"additional","affiliation":[{"name":"Saarland University","place":["Saarbr\u00fccken, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abdel-Halim","sequence":"additional","affiliation":[{"name":"German University in Cairo","place":["Cairo, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2013.03.012"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1006\/dbio.2002.0675"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi700251n"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/febs.12411"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11391"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e06-08-0668"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2010.07956.x"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3590497"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169355"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M104091200"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature04678"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3550609"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01047-09"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2013.09.009"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.2034211"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.102574"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2008.06751.x"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2009.08.009"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI63623"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2015.03.004"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e04-12-1085"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2010.11.021"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2010.07955.x"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2010.07954.x"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.116.013342"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M707358200"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867329666220620162018"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2010.06769.x"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-023-01702-x"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M606147200"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.253"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2019.104268"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43820-4"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2017.12.002"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2017.12.003"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316128"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115521"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112656"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI135937"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098853"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-16-0323-T"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2018.04.005"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.11.017"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2009.10.043"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2015.05.015"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104139"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c02050"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092263"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01624"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.132594"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.12.005"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2018.10.002"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2019.05.006"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2022.100185"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep28241"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110475"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01583-19"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2009.07346.x"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201300325"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.114062"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b00185"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c01130"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.148124"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.116098"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2024.117925"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2903"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.e14670"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007540"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00988"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.374504"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm501853m"},{"key":"e_1_3_6_74_1","unstructured":"Biosplice announces the submission of its new drug application (NDA) to the FDA for lorecivivint (LOR) to treat knee osteoarthritis - BioSpace [Internet]. [cited 2026 Jan 27]. Available from: https:\/\/www.biospace.com\/press-releases\/biosplice-announces-the-submission-of-its-new-drug-application-nda-to-the-fda-for-lorecivivint-lor-to-treat-knee-osteoarthritis"},{"key":"e_1_3_6_75_1","doi-asserted-by":"crossref","unstructured":"De Lombaert S. Heterocyclic compounds as DYRK1A inhibitors. WO2023107714. 2023.","DOI":"10.1201\/9781003377016-1"},{"key":"e_1_3_6_76_1","unstructured":"De Lombaert S. Compounds for use in treating neurological disorders. WO2023107722. 2023."},{"key":"e_1_3_6_77_1","unstructured":"De Lombaert S. Cyclic compounds and their use for the treatment of neurological disorders. WO2023107723. 2023."},{"key":"e_1_3_6_78_1","unstructured":"Lee H Kim KY Lee GH et al. DYRK1 inhibitor pyrrolo[3 2-c]pyridine derivative and use thereof. WO2023277331. 2023."},{"key":"e_1_3_6_79_1","unstructured":"Hulme C Rokey S Thorne C et al. Small molecule inhibitors of DYRK\/CLK and uses thereof. WO2023250083. 2023."},{"key":"e_1_3_6_80_1","unstructured":"Hulme C Fistrovich A Shaw A et al. Small molecule inhibitors of DYRK1A and uses thereof. WO2023250082. 2023."},{"key":"e_1_3_6_81_1","unstructured":"Hulme C Dunckley TSY. Small molecule inhibitors of DYRK1A and uses thereof. WO2017040993. 2017."},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.1101\/2025.03.26.645490"},{"key":"e_1_3_6_83_1","unstructured":"Qingchun Z Huanhua C Xinzhu L et al. 6-(1H-pyrrolo [2 3-b] pyridine-3-yl) quinazoline-4-amine derivative as well as preparation method and application thereof. CN118184650. 2024."},{"key":"e_1_3_6_84_1","unstructured":"Kc SK Mak CC Eastman BW et al. 6-(5-membered heteroaryl)isoquinolin-3-yl-(5-membered heteroaryl) carboxamides and preparation and use thereof. WO2019084496. 2019."},{"key":"e_1_3_6_85_1","unstructured":"Kc SK Mak CC Cao J et al. Diazanaphthalen-3-yl carboxamides and preparation and use thereof. WO2019089835. 2019."},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13000"},{"key":"e_1_3_6_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2017.08.015"},{"key":"e_1_3_6_88_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.087795"},{"key":"e_1_3_6_89_1","unstructured":"Kc SK Mittapalli GK Hofilena BJ et al. Isoquinolin-3-yl carboxamides and preparation and use thereof. WO2017189823. 2017."},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.132024"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-024-00731-9"},{"key":"e_1_3_6_92_1","unstructured":"Mittapalli GK Kc SK Mak CC et al. Pyrrolo[2 1-f][1 2 4]triazines derivatives as inhibitors of DYRK1A. WO2023064366. 2023."},{"key":"e_1_3_6_93_1","unstructured":"Mittapalli GK Mak CC Hofilena BJ et al. Pyrrolo[2 1-f][1 2 4]triazines and preparation and uses thereof. WO2024211797. 2024."},{"key":"e_1_3_6_94_1","unstructured":"Mittapalli GK Mak CC Vakiti RR et al. 4-alkoxypyrrolo[2 1-f][1 2 4]triazines and preparation and uses thereof. WO2023250156. 2023."},{"key":"e_1_3_6_95_1","unstructured":"Mittapalli GK Mak CC Vakiti RR et al. 4-alkoxypyrrolo[2 1-f][1 2 4]triazines and preparation and uses thereof. WO2025137469. 2025."},{"key":"e_1_3_6_96_1","unstructured":"Mittapalli GK Mak CC Turner LD et al. 4-aminopyrrolo[2 1-f][1 2 4]triazines and preparation and uses thereof. WO2024097391. 2024."},{"key":"e_1_3_6_97_1","unstructured":"Mittapalli GK Mak CC Eastman BW et al. 4-Aminopyrrolo[2 l-f][l 2 4]triazines and preparation and uses thereof. WO2025231425. 2025."},{"key":"e_1_3_6_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-01893-w"},{"key":"e_1_3_6_99_1","unstructured":"Kumar K Wang P Sanchez R et al. Kinase inhibitor compounds and compositions and methods of use. US20240132494. 2023."},{"key":"e_1_3_6_100_1","unstructured":"Qingchun Z Wenwu L Xin L et al. Beta-carboline GSK3beta\/DYRK1A dual inhibitor and preparation method thereof and application of beta-carboline GSK3beta\/DYRK1A dual inhibitor in resisting Alzheimer\u2019s disease. CN113072552. 2021."},{"key":"e_1_3_6_101_1","unstructured":"Qingchun Z Jingsong Q Wenwu L et al. Beta-carboline compound preparation method thereof and application of beta-carboline compound in resisting Alzheimer\u2019s disease. CN117143097. 2023."},{"key":"e_1_3_6_102_1","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202300404"},{"key":"e_1_3_6_103_1","unstructured":"Olson DE Warren H. Dual inhibitors of DYRK1A and 5-HT2 for treating a brain disorder. WO2024220485. 2024."},{"key":"e_1_3_6_104_1","unstructured":"Deau E George P Meijer L et al. Imidazolone derivatives as inhibitors of protein kinases in particular DYRK1A CLK1 and\/or CLK4. WO2023072969. 2023."},{"key":"e_1_3_6_105_1","unstructured":"Chen Y Lian D Liu Y et al. Use of heterocyclic derivatives with cardiomyocyte proliferation activity for the treatment of heart disease. JP2023506321A;. 2023."},{"key":"e_1_3_6_106_1","unstructured":"Kc SK Mak CC Eastman BW et al. Pyrazole derivatives as modulators of the WNT\/B-catenin signaling pathway. WO2020150545. 2020."},{"key":"e_1_3_6_107_1","unstructured":"Plonowski A Elias KA Brown SD et al. Methods of treating neurodegenerative diseases. WO2020046975. 2020."},{"key":"e_1_3_6_108_1","unstructured":"Jinlei B Zhiyu L Mai L et al. 3-ethynyl-5-(1H-1 2 3-triazole-4-yl)-1H-indazole compound and application thereof. CN115785071. 2023."},{"key":"e_1_3_6_109_1","unstructured":"Li Z Bian J Song J et al. 5-pyridine-1H-indazole compound for targeted inhibition of CLK2 and use of compound. WO2024051720. 2024."},{"key":"e_1_3_6_110_1","unstructured":"Sun L. Inhibitors of DYRK1A. WO2024249488. 2024."},{"key":"e_1_3_6_111_1","unstructured":"Asamitsu S Tojo D Urabe H et al. Amine derivative. EP4215534A1. 2023."},{"key":"e_1_3_6_112_1","unstructured":"Zaid GH Blagg BSJ West CE. Inhibition of DYRK1A kinase. WO2022051291. 2022."},{"key":"e_1_3_6_113_1","unstructured":"Foley C Hulme C. Small molecule inhibitors of DYRK\/CLK and uses thereof. US20220041590A1. 2022."},{"key":"e_1_3_6_114_1","unstructured":"Hulme C Schofield K Becker W et al. DYRK\/CLK PROTACs and uses thereof. WO2024108009. 2024."},{"key":"e_1_3_6_115_1","unstructured":"Hulme C Schofield K Rokey SN et al. DYRK\/CLK PROTACs and uses thereof. WO2025080753. 2025."},{"key":"e_1_3_6_116_1","unstructured":"Shin JL Kook LS Tripathi SK et al. Nucleoside derivatives having multi-target kinase inhibitory activity and pharmaceutical compositions containing same for preventing and treating cancer. KR1020240023587. 2024."},{"key":"e_1_3_6_117_1","unstructured":"Gray NS Hatcher JM Choi H. Macrocyclic inhibitors of DYRK1A. US20220112201. 2022."},{"key":"e_1_3_6_118_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.1c00630"},{"key":"e_1_3_6_119_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2017.1360285"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2026.2694586","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/13543776.2026.2694586","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2026.2694586","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T09:33:54Z","timestamp":1785749634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2026.2694586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":117,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,3]]}},"alternative-id":["10.1080\/13543776.2026.2694586"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2026.2694586","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-03-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}